Levin Capital Strategies, L.P. Delcath Systems, Inc. Transaction History
Levin Capital Strategies, L.P.
- $952 Million
- Q2 2024
A detailed history of Levin Capital Strategies, L.P. transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 15,000 shares of DCTH stock, worth $138,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,000
Previous 54,969
72.71%
Holding current value
$138,000
Previous $262,000
52.29%
% of portfolio
0.01%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding DCTH
# of Institutions
58Shares Held
7.84MCall Options Held
118KPut Options Held
69.9K-
Aigh Capital Management LLC Baltimore, MD2.4MShares$22.1 Million7.28% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.67MShares$15.3 Million2.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA996KShares$9.17 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA336KShares$3.09 Million0.56% of portfolio
-
Geode Capital Management, LLC Boston, MA245KShares$2.25 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $79.1M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...